{
    "nctId": "NCT04659980",
    "briefTitle": "Preventing Taxane-related Peripheral Neuropathy, Pain and Nail Toxicity: A Prospective Self-controlled Trial Comparing Hilotherapy With Frozen Gloves in Early Breast Cancer",
    "officialTitle": "Hilotherapy vs Frozen Gloves for Preventing Taxane-related Peripheral Neuropathy, Pain and Nail Toxicity in Breast Cancer",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NON_RANDOMIZED",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 62,
    "primaryOutcomeMeasure": "any-grade incidence of side-effects at the extremities (peripheral neuropathy, pain, nail toxicity)",
    "eligibilityCriteria": "Inclusion criteria:\n\n* adult (\u226518 years) patients with breast cancer\n* treated with weekly paclitaxel 80 mg/m\u00b2 (12 cycles) or three-weekly docetaxel 75 mg/m\u00b2 (4 or 6 cycles) in an adjuvant or neo-adjuvant setting.\n\nExclusion criteria:\n\n* peripheral neuropathy or pain in the extremities at baseline, regardless of whether this was related to a prior chemotherapy treatment or another condition\n* Raynaud's phenomenon, cold intolerance or any condition to the nails or peripheral blood vessels that could pose a risk to the compliance with the study interventions\n* insufficient understanding of the Dutch language for self-reporting the side-effects under investigation\n\nPatients were excluded from the analysis if they received less than two thirds of planned treatment cycles, for other reasons than the side-effects investigated in this study.",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}